AMS Technologies presents a new compact hyperspectral imager product family from spectral sensing company BaySpec.

Hyperspectral imaging is well recognized for its potential, but widespread adoption has been limited by both bulk and cost. With BaySpec's miniaturized Hyperspectral OCI™-series handheld device based on low-cost semiconductor manufacturing processes, the cost of generating Hyperspectral images will drop significantly, enabling them to be used more frequently and at more sampling platforms...

The University of Sheffield-based Insigneo Institute is developing an ‘in silico’ (computer simulated) model of the human body that will enable simulation of the effects of drugs and treatments on the human body.

An Institute founded one year ago at the University of Sheffield is showcasing the first phase of technology that will lead to the creation of a virtual human body and revolutionise global healthcare. The Insigneo Institute at the University of Sheffield has the objective of creating an in silico (computer simulated) replica of the human body that will enable the virtual testing of bespoke treatments.  When complete, the Virtual Physiological Human will transform the economics and practicalities of modern medical treatment and medical research...

Beckman Coulter Life Sciences Offers New Software Package For Data Acquisition in Cytometry, For Use Across Cell Analysis Applications

Kaluza for Gallios software combines cutting edge data acquisition tools with remarkable ease of use to increase efficiency and performance in the cell characterization and analysis workflow of core research laboratories. Researchers at all levels of experience can learn the system quickly using this next generation acquisition software for the Beckman Coulter Gallios cytometer. Users maximize productivity and data output through novel functionalities, such as the ability to set up experimental protocols offline and a Gallios simulator, which facilitates instrument training without running live experiments. The new software combines with Kaluza Analysis, a leading cytometry data analysis programme, and together the packages provide a total cytometry data management solution...

Asynt reports on how the School of Chemistry at Monash University in Melbourne, Australia has invested in a range of its DrySyn MULTI heating block systems to support its ground breaking synthetic research in photovoltaics, water splitting and nanoimaging.

In order to improve safety in his laboratories, Leone Spiccia, Professor of Chemistry at Monash University sought laboratory apparatus to replace oil bath systems traditionally used for all general syntheses. He comments  “After a lengthy evaluation process we decided to switch to DrySyn heating block systems as they are inherently safer to use than heated oil baths, avoiding the risk of oil spillage that can lead to burns when hot or may cause someone to slip over”. Professor Spiccia added “We are using DrySyn products inside our nanoimaging team...

Oxford Global are pleased to announce the return of the Pharma R&D Europe Series, the leading pharmaceutical discussion forum in Europe.

The series is made up of the following events:

• 15th Annual Drug Discovery Summit
• 6th Annual Drug Development Congress
• 2nd Annual Discovery Chemistry & Drug Design Congress

Over the next few years, the University Medical Center (UMC) Utrecht and Quirem Medical will be working closely together to maximize the benefits of using holmium microspheres to treat liver cancer patients worldwide.

To mark its 30th anniversary - Micronic has published a new product range catalogue and launched a new easy access website that offers a wide variety of useful information to organisations involved with safeguarding one of their most valuable assets - their samples.

The new Micronic 2014 catalogue contains all you need to know about sample storage, handling and management. Available in A4 hard copy, or as a pdf download, the catalogue provides photographs and detailed technical information relating to Micronic's comprehensive range of sample storage tubes, racks, accessories and instruments...

The new Zetasizer NanoSampler from Malvern Instruments is a versatile, compact, fully automated sample delivery system for the Zetasizer Nano, the most widely used system for nanoparticle and colloid characterization.

Delivering precise and reproducible automated sample loading, and accommodating up to 96 sample vials, the NanoSampler enables unattended operation of the Zetasizer Nano, to maximize analytical productivity. It is especially suitable for laboratories where reproducibility is critical and where multivariate studies are routine. The new NanoSampler will work with all of the sizing systems in the Zetasizer Nano instrument range. This range includes both exceptionally high performance and entry level systems that measure particle and molecular size using dynamic light scattering, covering a size range from less than one nanometer up to several microns....

Purite has launched a new swap out scheme that will save money and bring peace of mind to laboratories that run water purification units.

TAP Biosystems has announced that its new ambr250™ automated mini bioreactor system has already been chosen by a number of major pharmaceutical, biotech and CRO firms as a high-throughput, scale-down bioreactor model for their process development and optimisation programmes.

Dutch Software Company GENALICE announced that it has reached an agreement on a multi-million euro capital investment from Redbrae, a consortium of US- and UK-based private equity investors.

The dramatic improvement in outcome for children with acute lymphoblastic leukemia is one of the major achievements in hematology in the last 40 years. However, while 90% of children with this disease can now be cured, the outlook has not been so good for the less common type of childhood leukemia, acute myeloid leukemia (AML).

Although only 1 in 7 children with leukemia have AML, half of these children will die from their disease. The challenge now is to harness the new developments in genomics to improve the outcome for these children. At the 19^th Congress of the European Hematology Association (EHA), we will learn about the state-of-the-art in management of childhood AML.  New concepts in the way AML develops and the way AML cells 'hijack' the main sites of normal blood production within the body will be presented....

EU support boosts development of therapeutic vaccines against Parkinson's and Multiple System Atrophy. AFFiRiS leads consortium.

An international consortium of top European research teams has received significant EU funding for the development of therapeutic vaccines against Parkinson's Disease (PD) and Multiple System Atrophy (MSA). Led by the Austrian biotech company AFFiRiS AG, the consortium will use a novel tandem strategy to advance the development of two therapeutic vaccine candidates in parallel. They are both unique in the potential for disease modification, something which is sorely missing in PD as well as in MSA. Both candidates target a protein called alpha-synuclein, which plays a key role in the onset and progression of PD and MSA. Additionally, the group attempts to identify biomarkers with diagnostic and prognostic value....

Dutch Software Company GENALICE today announced at the 14^th Bio-IT World Conference & Expo that it has started discussions with Intel® about a product development as well as a product delivery partnership.

On 12/12 last year, GENALICE launched its groundbreaking DNA processing software; GENALICE MAP. On a simple dual Intel® Xeon® E5 server the company was capable to map the short reads of 42 complete human and 42 full tomato genomes within 24 hours. The software is designed to optimally make use of the modern hardware architecture of these commodity Intel processors....

Sygnature Discovery Limited, the UK’s largest independent integrated drug discovery provider, today announced the appointment of Dr Gerry Thomas to the pivotal role of Director of Business Development.

Board Director, Dr Paul Clewlow, stated, “I am delighted to welcome Gerry Thomas to Sygnature Discovery.  Gerry is a very experienced industry professional having spent over 20 years in drug discovery and development at Boots Pharmaceuticals, BASF/Knoll, OSI Pharmaceuticals, Prosidion and Shire Pharmaceuticals.  Sygnature Discovery has ambitious plans to expand its customer base and Gerry will be instrumental in promoting Sygnature’s integrated drug discovery capabilities and expertise across Europe and North America....

Quotient Clinical, the Translational Pharmaceutics Company, has announced the extension of its Translational Pharmaceutics™ platform into patient-focused cancer drug development.

Quotient will employ its real-time, flexible manufacturing capabilities to supply specialist oncology centers with drug products to support first-in-patient and proof-of-concept programs. Translational Pharmaceutics integrates real-time drug product manufacturing and clinical testing, using processes that significantly reduce the timelines and cost of early stage drug development....

Waters Corporation (NYSE:WAT) today expanded its family of CORTECS® Columns with the introduction of a new line of 2.7 micron silica-based, solid-core particle columns that set a new standard for HPLC column performance.

HORIBA UK Ltd, Medical Division, has introduced a new version of its Quality Slide Program (QSP) service specifically designed to readily meet new CPA guidelines for evaluating and reporting on staff competency and training for blood cell identification in line with ISO 15189. As a unique digital blood cell morphology QC and training program, HORIBA’s QSP also helps to standardise blood film review.

ISO 15189 Medical Laboratory Accreditation is a tool to demonstrate the quality and competence of medical laboratories and ensure delivery of timely and accurate results. Key to this is on-going assessment of laboratory staff technical skills. The new version of HORIBA’s QSP offers enhanced recording of staff competency and training in blood cell identification, where results may sometimes be subjective. Intuitive and easy-to-use, QSP can be fully customised to meet UK working practices...

The Clinical and Laboratory Standards Institute (CLSI) has published an updated version of H52-A2—Red Blood Cell Diagnostic Testing Using Flow Cytometry; Approved Guideline—Second Edition.

This standard addresses the diagnostic red blood cell (RBC) assays performed as fluorescence-based assays on a flow cytometry platform; including testing procedures for fetomaternal hemorrhage detection, paroxysmal nocturnal hematuria screening, membrane defect anemia testing for hereditary spherocytosis, and nucleated RBC counting. Points of validation and quality control, and caveats of interpretation are also discussed.

OHAUS, a leading worldwide manufacturer of scales and balances, has been extremely successful with the Explorer® Series. This line of ingenious balances offers advanced applications that simplify even the most complex laboratory measurements.

OHAUS Explorer® with its unmatched functionality and high-performance has received two prominent awards. One of them was granted by the American magazine Laboratory Equipment that gave Explorer® the 2013 “Readers' Choice” Award for best balance. The voters were focusing on products that lead the industry in technology... 

The US Federal Drug Administration Gulf Coast Seafood Laboratory has increased the efficiency of preparing its agar plates for microbiological research using an INTEGRA MEDIAJET vario automated petri dish filling system.

Located in Dauphin Island (AL), the FDA’s Gulf Coast Seafood Laboratory (GCSL) site is used by the Center for Food Safety and Applied Nutrition (CFSAN) to conduct research programs related to seafood safety, especially seafood harvested from the Gulf of Mexico. The US FDA operates a mandatory safety program for all fish and fishery products under the provisions of the Federal Food, Drug and Cosmetic Act, the Public Health Service Act, and related regulations. The FDA program includes research, inspection, compliance, enforcement, outreach and the development of regulations and industry guidance...